Julien Mahe Aurélie Meurette Anne Moreau Caroline Vercel Pascale Jolliet
10.2147/DDDT.S42138
Drug Des Devel Ther
2013 Aug 7;7:723-8.
antiangiogenic activity hemolytic-uremic syndrome interferon beta thrombotic microangiopathy
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/23950639/
Adjuvants, Immunologic / adverse effects Interferon-beta / adverse effects Kidney Diseases / chemically induced Multiple Sclerosis / drug therapy Thrombotic Microangiopathies / chemically induced
Adjuvants, Immunologic / adverse effects Interferon-beta / adverse effects Kidney Diseases / chemically induced Multiple Sclerosis / drug therapy Thrombotic Microangiopathies / chemically induced Case Reports Adult Female Humans Interferon beta-1a Adjuvants, Immunologic Interferon-beta Interferon beta-1a
PMC3741076
23950639
Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis
2013